State Key Laboratory of Electroanalytical Chemistry, Changchun Institute of Applied Chemistry, Chinese Academy of Sciences, Changchun, Jilin 130022, PR China ...
NICE has said that the NHS should not fund Bristol-Myers Squibb’s multiple sclerosis pill Zeposia (ozanimod) for relapsing multiple sclerosis in first draft guidance. The cost-effectiveness body ...
College of Biotechnology, Tianjin University of Science & Technology, Tianjin 300457, P. R. China Key Laboratory of Industrial Fermentation Microbiology of the Ministry of Education, Tianjin ...
2018). According to the literature, the presence of two biogenic amines, octopamine (OA) and tyramine (TA), in high concentrations in the nervous systems of invertebrates shows their pivotal role in ...
In October 2020, Bristol Myers Squibb’s Zeposia was approved for the treatment of relapsing-remitting MS (RRMS) with a label that, unlike Gilenya, allowed for prescribing to treatment-naive ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results